Scientific Director of REMEDI
The therapeutic application of adult stem cells, especially mesenchymal stem cells (MSCs) from bone marrow.
Characterisation of novel biomarkers for schizophrenia.
Mikey's research is in examining the role of modified human endothelial progenitor cells and mesenchynal stem cells in the treatment of cardiovasuclar disease.
Stem cells, neuronal differentiation, CNS diseases and underlying mechanisms
Mesenchymal Stromal Cell Therapy for Acute Lung Injury
Linda investigates how microRNAs regulate the differentiation of MSCs.
Linda is also interested in the therapeutic potential of adult stem cells, particularly looking at the nervous, heart and musculoskeletal system.
Cardiovasular, Mesenchymal Stem Cells (MSCs), Angiogenic potential of microencapsulated MSCs
Cell therapy for diabetic foot ulcers
Stem Cell Commitment, Chondrogenesis, Transcriptional Networks
Mesenchymal stem cells, Haematopoietic stem cells, Stem Cell Biology
Roisin investigates the potential of human MSCs as vectors for therapeutic gene delivery to breast tumor tissue
Gene therapy, Mesenchymal stem cells
iPS stem cells, neuroscience
Cellular and Tissue Engineering Strategies for Bone Regeneration
Professor of Anaesthesia, NUI Galway
Acute Lung Injury – pathogenesis and therapeutic strategies. Development of therapeutic strategies for acute lung injury and ARDS